Mishustin: Russia has opportunities to create fundamentally new… (россия · лекарство · препарат)
Mishustin: Russia has opportunities to create fundamentally new medicines. Russia needs to transition to the development of fundamentally new pharmaceuticals and medical technologies.
Consensus
- The Russian government has approved a plan to develop new pharmaceuticals and medical technologies by 2030.
- New drugs and treatments should be introduced annually into practice.
- Key federal agencies including the Ministry of Health, Ministry of Science and Higher Education, Roszdravnadzor, FMBA, and Minpromtorg are responsible for implementation.
- Annual reports on progress will be submitted to the government starting next year.
- The goal includes achieving technological leadership in healthcare within Russia.
Points of divergence
- The plan specifically includes products of tissue engineering, biomedical cell products, and radiopharmaceuticals as part of the new medical developments by 2030. — riamo
- Prime Minister Mikhail Mishustin emphasized that Russia has all necessary capabilities to create fundamentally new drugs with radically different characteristics, citing Rostec's achievements in oncology and diagnostic tools as examples. — kommersant
- Rostec reported delivering 102,000 units of medical equipment and over 90 million consumables for neonatology, cardiology, gynecology, among others in the past year. — kommersant
- Rostec has completed testing of a mobile device for non-invasive therapy of breast and thyroid tumors called 'Meduza' and registered an oncological scanner that reduces diagnosis time to minutes, with serial production underway. — kommersant
Coverage (2 sources)
- By 2030 Russia will develop new drugs and treatment methods — РИАМО
- Mishustin: Russia has opportunities to create fundamentally new medicines — Коммерсантъ